We are live on ! Find out more
FEED

ENvue Medical Inc

7 hedge funds and large institutions have $327K invested in ENvue Medical Inc in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more capital invested

Capital invested by funds: $123K → $327K (+$204K)

0.11% more ownership

Funds ownership: 0.05%0.16% (+0.11%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

13% less funds holding

Funds holding: 87 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

FEED Hedge Fund Activity: Q1 2024 in Review

7 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in ENvue Medical Inc (FEED) for Q1 2024, worth a combined $327K — up 166% from $123K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of FEED and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $247K. The largest seller was UBS Group, exiting entirely with an estimated $4.07K sold.

  • 7 institutional investors held ENvue Medical Inc (FEED) as of Q1 2024, down from 8 in Q4 2023.
  • Funds reported $327K of ENvue Medical Inc stock for Q1 2024, up 166% quarter-over-quarter.
  • 2 funds opened new ENvue Medical Inc positions in Q1 2024 and 3 closed out, a net change of -1 holder.
  • The largest ENvue Medical Inc buyer in Q1 2024 was Armistice Capital, an estimated $247K added.
  • The largest ENvue Medical Inc seller in Q1 2024 was UBS Group, an estimated $4.07K sold.

Based on aggregated 13F filings for Q1 2024.